Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Medicaid prior authorization (PA) policies for treatment of hepatitis C virus (HCV) with direct‐acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA requirements on treatment uptake and to determine the factors associated with DAA treatment among Florida Medicai...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Haesuk Park, Hyun Jin Song, Xinyi Jiang, Linda Henry, Robert L. Cook, David R. Nelson
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Health/LWW 2021-02-01
Edice:	Hepatology Communications
On-line přístup:	https://doi.org/10.1002/hep4.1634
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!